-
1
-
-
79952231921
-
Management of hepatocellular carcinoma: An update
-
21374666 10.1002/hep.24199
-
J Bruix M Sherman 2011 Management of hepatocellular carcinoma: an update Hepatology 53 1020 1022 21374666 10.1002/hep.24199
-
(2011)
Hepatology
, vol.53
, pp. 1020-1022
-
-
Bruix, J.1
Sherman, M.2
-
3
-
-
0034647327
-
Are increasing 5-year survival rates evidence of success against cancer?
-
10865276 10.1001/jama.283.22.2975 1:STN:280:DC%2BD3czisFKkug%3D%3D
-
HG Welch LM Schwartz S Woloshin 2000 Are increasing 5-year survival rates evidence of success against cancer? JAMA 283 2975 2978 10865276 10.1001/jama.283.22.2975 1:STN:280:DC%2BD3czisFKkug%3D%3D
-
(2000)
JAMA
, vol.283
, pp. 2975-2978
-
-
Welch, H.G.1
Schwartz, L.M.2
Woloshin, S.3
-
4
-
-
28844480321
-
Management of hepatocellular carcinoma
-
16250051 10.1002/hep.20933
-
J Bruix M Sherman 2005 Management of hepatocellular carcinoma Hepatology 42 1208 1236 16250051 10.1002/hep.20933
-
(2005)
Hepatology
, vol.42
, pp. 1208-1236
-
-
Bruix, J.1
Sherman, M.2
-
5
-
-
4243430012
-
-
Oxford Centre for Evidence-based Medicine March
-
Phillips B, Ball C, Sackett D, et al. Oxford Centre for Evidence-based Medicine, Levels of Evidence (March 2009). http://www.cebm.net/index.aspx?o= 1025.
-
(2009)
Levels of Evidence
-
-
Phillips, B.1
Ball, C.2
Sackett, D.3
-
6
-
-
0027715844
-
Estimating diagnostic accuracy from multiple conflicting reports: A new meta-analytic method
-
10.1177/0272989X9301300408
-
B Littenberg LE Moses 1993 Estimating diagnostic accuracy from multiple conflicting reports: a new meta-analytic method Med Decis Mak 13 1313 1321 10.1177/0272989X9301300408
-
(1993)
Med Decis Mak
, vol.13
, pp. 1313-1321
-
-
Littenberg, B.1
Moses, L.E.2
-
7
-
-
27744539432
-
GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma
-
16137783 10.1016/j.jhep.2005.05.028 1:CAS:528:DC%2BD2MXht1egsrvE
-
JA Marrero PR Romano O Nikolaeva, et al. 2005 GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma J Hepatol 43 1007 1012 16137783 10.1016/j.jhep.2005.05.028 1:CAS:528:DC%2BD2MXht1egsrvE
-
(2005)
J Hepatol
, vol.43
, pp. 1007-1012
-
-
Marrero, J.A.1
Romano, P.R.2
Nikolaeva, O.3
-
8
-
-
78649899920
-
Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma
-
20876776 10.1136/gut.2010.214916 1:CAS:528:DC%2BC3MXpvFCr
-
Y Mao H Yang H Xu, et al. 2010 Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma Gut 59 1687 1693 20876776 10.1136/gut.2010.214916 1:CAS:528:DC%2BC3MXpvFCr
-
(2010)
Gut
, vol.59
, pp. 1687-1693
-
-
Mao, Y.1
Yang, H.2
Xu, H.3
-
9
-
-
38849106118
-
Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma
-
17962206 10.1093/annonc/mdm448 1:STN:280:DC%2BD1c%2Fotlemuw%3D%3D
-
C Porta M De Amici S Quaglini, et al. 2008 Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma Ann Oncol 19 353 358 17962206 10.1093/annonc/mdm448 1:STN:280:DC%2BD1c%2Fotlemuw%3D%3D
-
(2008)
Ann Oncol
, vol.19
, pp. 353-358
-
-
Porta, C.1
De Amici, M.2
Quaglini, S.3
-
10
-
-
33847344307
-
Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma
-
17140760 10.1016/j.ejso.2006.10.036
-
CY Hsia TI Huo SY Chiang, et al. 2007 Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma Eur J Surg Oncol 33 208 212 17140760 10.1016/j.ejso.2006.10.036
-
(2007)
Eur J Surg Oncol
, vol.33
, pp. 208-212
-
-
Hsia, C.Y.1
Huo, T.I.2
Chiang, S.Y.3
-
11
-
-
26444523991
-
SCCA antigen combined with alpha-fetoprotein as serologic markers of HCC
-
15906357 10.1002/ijc.21189 1:CAS:528:DC%2BD2MXhtFant7jN
-
G Giannelli F Marinosci P Trerotoli, et al. 2005 SCCA antigen combined with alpha-fetoprotein as serologic markers of HCC Int J Cancer 117 506 509 15906357 10.1002/ijc.21189 1:CAS:528:DC%2BD2MXhtFant7jN
-
(2005)
Int J Cancer
, vol.117
, pp. 506-509
-
-
Giannelli, G.1
Marinosci, F.2
Trerotoli, P.3
-
12
-
-
34347334468
-
Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients
-
10.1016/j.cca.2007.05.014 1:CAS:528:DC%2BD2sXnsFWlsrk%3D
-
G Giannelli E Fransvea P Trerotoli, et al. 2007 Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients Clin Chim 383 147 152 10.1016/j.cca.2007.05.014 1:CAS:528:DC%2BD2sXnsFWlsrk%3D
-
(2007)
Clin Chim
, vol.383
, pp. 147-152
-
-
Giannelli, G.1
Fransvea, E.2
Trerotoli, P.3
-
13
-
-
58149216066
-
Evaluation of serum squamous cell carcinoma antigen as a novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients
-
19112206 10.4103/0019-509X.44666 1:STN:280:DC%2BD1M%2FhtVOnsA%3D%3D
-
MM Hussein AA Ibrahim HM Abdella, et al. 2008 Evaluation of serum squamous cell carcinoma antigen as a novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients Indian J Cancer 45 167 172 19112206 10.4103/0019-509X.44666 1:STN:280:DC%2BD1M%2FhtVOnsA%3D%3D
-
(2008)
Indian J Cancer
, vol.45
, pp. 167-172
-
-
Hussein, M.M.1
Ibrahim, A.A.2
Abdella, H.M.3
-
14
-
-
65649126299
-
Diagnosis of hepatocellular carcinoma
-
19294759 10.3748/wjg.15.1301
-
AI Gomaa SA Khan ELS Leen, et al. 2009 Diagnosis of hepatocellular carcinoma World J Gastroenterol 15 1301 1314 19294759 10.3748/wjg.15.1301
-
(2009)
World J Gastroenterol
, vol.15
, pp. 1301-1314
-
-
Gomaa, A.I.1
Khan, S.A.2
Leen, E.L.S.3
-
15
-
-
84856387903
-
Identification of osteopontin as a novel marker for early hepatocellular carcinoma
-
21953299 10.1002/hep.24703 1:CAS:528:DC%2BC38Xht1yqtb8%3D
-
S Shang A Plymoth S Ge, et al. 2012 Identification of osteopontin as a novel marker for early hepatocellular carcinoma Hepatology 55 483 490 21953299 10.1002/hep.24703 1:CAS:528:DC%2BC38Xht1yqtb8%3D
-
(2012)
Hepatology
, vol.55
, pp. 483-490
-
-
Shang, S.1
Plymoth, A.2
Ge, S.3
|